34 related articles for article (PubMed ID: 8911509)
1. Morphologic features of prostate cancer-encased native vessels: An image analysis study.
Fernandez Gonzalez De La Vega C; Duenweg S; Jain P; Rubenstein SI; Bobholz S; Barrett MJ; LaViolette PS; Iczkowski KA
Pathol Res Pract; 2024 Apr; 256():155239. PubMed ID: 38461692
[TBL] [Abstract][Full Text] [Related]
2. Statistical Shape Model for Manifold Regularization: Gleason grading of prostate histology.
Sparks R; Madabhushi A
Comput Vis Image Underst; 2013 Sep; 117(9):1138-1146. PubMed ID: 23888106
[TBL] [Abstract][Full Text] [Related]
3. Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer.
Schonhoft JD; Zhao JL; Jendrisak A; Carbone EA; Barnett ES; Hullings MA; Gill A; Sutton R; Lee J; Dago AE; Landers M; Bakhoum SF; Wang Y; Gonen M; Dittamore R; Scher HI
Cancer Res; 2020 Nov; 80(22):4892-4903. PubMed ID: 32816908
[TBL] [Abstract][Full Text] [Related]
4. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer.
Yao N; Jan YJ; Cheng S; Chen JF; Chung LW; Tseng HR; Posadas EM
Am J Clin Exp Urol; 2018; 6(2):43-54. PubMed ID: 29666832
[TBL] [Abstract][Full Text] [Related]
5. Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer.
Veltri RW; Christudass CS
Adv Exp Med Biol; 2014; 773():77-99. PubMed ID: 24563344
[TBL] [Abstract][Full Text] [Related]
6. Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.
Olkhov-Mitsel E; Van der Kwast T; Kron KJ; Ozcelik H; Briollais L; Massey C; Recker F; Kwiatkowski M; Fleshner NE; Diamandis EP; Zlotta AR; Bapat B
Epigenetics; 2012 Sep; 7(9):1037-45. PubMed ID: 22874102
[TBL] [Abstract][Full Text] [Related]
7. Nuclear morphometry, nucleomics and prostate cancer progression.
Veltri RW; Christudass CS; Isharwal S
Asian J Androl; 2012 May; 14(3):375-84. PubMed ID: 22504875
[TBL] [Abstract][Full Text] [Related]
8. Improved prediction of prostate cancer recurrence through systems pathology.
Cordon-Cardo C; Kotsianti A; Verbel DA; Teverovskiy M; Capodieci P; Hamann S; Jeffers Y; Clayton M; Elkhettabi F; Khan FM; Sapir M; Bayer-Zubek V; Vengrenyuk Y; Fogarsi S; Saidi O; Reuter VE; Scher HI; Kattan MW; Bianco FJ; Wheeler TM; Ayala GE; Scardino PT; Donovan MJ
J Clin Invest; 2007 Jul; 117(7):1876-83. PubMed ID: 17557117
[TBL] [Abstract][Full Text] [Related]
9. Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning.
Venkataraman G; Ananthanarayanan V; Paner GP; He R; Masoom S; Sinacore J; Flanigan RC; Wojcik EM
Virchows Arch; 2006 Sep; 449(3):302-7. PubMed ID: 16896895
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost-effectiveness of prognostic markers in prostate cancer.
Calvert NW; Morgan AB; Catto JW; Hamdy FC; Akehurst RL; Mouncey P; Paisley S
Br J Cancer; 2003 Jan; 88(1):31-5. PubMed ID: 12556955
[TBL] [Abstract][Full Text] [Related]
11. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
[TBL] [Abstract][Full Text] [Related]
12. Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations.
Veltri RW; Partin AW; Miller MC
J Cell Biochem Suppl; 2000; Suppl 35():151-7. PubMed ID: 11389545
[TBL] [Abstract][Full Text] [Related]
13. Multivariate techniques to assess laboratory tests in cancer patients.
Winkel P; Statland BE
Immunol Ser; 1990; 53():27-38. PubMed ID: 2100560
[TBL] [Abstract][Full Text] [Related]
14. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei.
Veltri RW; Miller MC; Partin AW; Coffey DS; Epstein JI
Urology; 1996 Nov; 48(5):685-91. PubMed ID: 8911509
[TBL] [Abstract][Full Text] [Related]
15. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.
Khan MA; Walsh PC; Miller MC; Bales WD; Epstein JI; Mangold LA; Partin AW; Veltri RW
Cancer; 2003 Dec; 98(12):2583-91. PubMed ID: 14669277
[TBL] [Abstract][Full Text] [Related]
16. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
